Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
78.2M
-
Shares change
-
-5.36M
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
-$75.3M
-
Put/Call ratio
-
0.07
-
Number of buys
-
155
-
Number of sells
-
-115
-
Price
-
$13.89
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2024
349 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2024.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.2M shares
.
Largest 10 shareholders include Capital Research Global Investors (13.1M shares), Mondrian Investment Partners LTD (12.1M shares), MORGAN STANLEY (5M shares), GOLDMAN SACHS GROUP INC (4.21M shares), RENAISSANCE TECHNOLOGIES LLC (3.12M shares), BRANDES INVESTMENT PARTNERS, LP (2.9M shares), FMR LLC (2.57M shares), MILLENNIUM MANAGEMENT LLC (2.32M shares), MACQUARIE GROUP LTD (2.25M shares), and BlackRock Inc. (1.99M shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.